INS and Insulin resistance: Pioglitazone treatment significantly reduced the levels of plasma insulin and insulin resistance (19.4±4.0 mU/L and 4.64±0.33, respectively, P<0.05 for both) compared to the level of the fructose-drinking insulin resistance rats.